MEDICATIONS

Setmelanotide

Setmelanotide (Imcivree) is an injectable medication targeting a brain pathway controlling hunger, approved for rare genetic forms of obesity.

Setmelanotide (brand name Imcivree) is an injectable medication that targets a specific pathway in the brain controlling hunger. It is approved for certain rare genetic forms of obesity that begin in childhood and do not respond to diet and exercise alone.

Setmelanotide is a melanocortin-4 receptor (MC4R) agonist that restores signalling in the leptin-melanocortin pathway, which regulates energy homeostasis. It is indicated for obesity due to POMC, PCSK1, or LEPR deficiency confirmed by genetic testing, administered as a once-daily subcutaneous injection.

For patients with rare genetic obesity syndromes, conventional weight loss approaches often fail. Our doctor at NuLifeCare can help determine if genetic testing and targeted therapy like setmelanotide may be appropriate for your situation.

⚕️

Medical Disclaimer

This library is for general education and does not replace individual assessment by a qualified healthcare professional. Always consult a doctor for medical advice, diagnosis, or treatment.

← Back to Weight Management Library